Notably, TFs such as NF-kB and STAT3, key players in inflammatory pathways, were upregulated in patients with T2DM, highlighting the persistent immune activation and inflammatory environment characteristic of the disease (48). The gene discussed is STAT3; the disease is type 2 diabetes mellitus.